Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr;18(2):324-329.
doi: 10.1007/s12328-025-02099-x. Epub 2025 Feb 10.

Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) of the rectum

Affiliations
Review

Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) of the rectum

Hiroyuki Fujimura et al. Clin J Gastroenterol. 2025 Apr.

Abstract

A 75-year-old man presented to our hospital complaining of abdominal distention. He underwent lower gastrointestinal endoscopic examination, which indicated a raised tumor of 20 mm in diameter in the sigmoid colon transition region of the rectum. Endoscopic mucosal resection was performed with the aims of treatment and diagnosis. Histopathological examination revealed a moderately differentiated adenocarcinoma with neuroendocrine carcinoma, which was classified as a mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN). The tumor had highly invaded the submucosa and positive vertical margins. Computed tomography showed no obvious lymph node metastasis or distant metastasis, so the patient underwent high-level anterior resection of the remaining lesion. The final diagnosis was MiNEN, pT3(SS), INFb, Ly1c, V0, Pn1a, pPM0, pDM0, pRM0, pN1a, and pStage IIIb (TNM Classification of Malignant Tumors, 8th Edition). The patient is recurrence free at 3 years without postoperative adjuvant therapy. We report this case with a review of the literature.

Keywords: MANEC; MiNEN; NEC.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: All authors declared that they have no conflict of interest.

References

    1. Lepage C, Bouvier AM, Faivre J. Endocrine tumours: epidemiology of malignant digestive neuroendocrine tumours. Eur J Endocrinol. 2013;168:R77-83. - DOI - PubMed
    1. Klimstra DS, Kloppell G, La Rosa, et al. Classification of neuroendocrine neoplasm of the digestive system. In: WHO Classification of Tumours Editorial Board, eds. WHO classification of tumours: digestive system tumours, 5th ed. Lyon: International Agency for Research on Cancer. 2019, p. 16–21.
    1. Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76:182–8. - DOI - PubMed
    1. Chen MH, Kuo YJ, Yeh YC, et al. High neuroendocrine component is a factor for poor prognosis in gastrointestinal high-grade malignant mixed adenoneuroendocrine neoplasms. J Chin Med Assoc. 2015;78:454–9. - DOI - PubMed
    1. André TR, Brito M, Freire JG, et al. Rectal and anal canal neuroendocrine tumours. J Gastrointest Oncol. 2018;9:354–7. - DOI - PubMed - PMC

LinkOut - more resources